David A. Fraser

Silicon Storage Technology, Inc. designs, manufactures and markets nonvolatile memory solutions. It supplies flash memory semiconductor devices for the digital consumer, networking, wireless communications and the Internet computing markets. The firm produces and sells semiconductor products, including flash controllers and controller-based modules, smart card integrated circuits and modules, flash microcontrollers and radio frequency devices and modules. The company was founded in 1989 and is headquartered in San Jose, CA.

Sensor Platforms, Inc. develops algorithms and software platforms that enable smart phone and tablet apps to understand user contexts and intents. Its FreeMotion Library makes sensor fusion and user context awareness available in smartphones and tablets to combine and process data from installed sensors and microprocessors to better interpret users movements and situations and infer their intents. The company was founded by David M. Traversi, George Hsu and Herbert M. Dwight Jr. in 2004 and is headquartered in San Jose, CA.

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

K2M, Inc. manufactures and markets medical devices. It offers deformity correction systems, spinal stabilization systems, lateral access systems, minimally invasive systems, and, constrained and translational cervical plates. The company was founded by John Philip Kostuik and Eric Major in January 2004 and is headquartered in Leesburg, VA.

BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

Vorago Technologies, Inc. operates as a fabless semiconductor company. Its products include RH 8Mb Dual Port SRAM, HT 8Mb Dual Port SRAM, RH 16Mb Asynchronous SRAM and RH 18Mb Sync Burst SRAM. The firm provides radiation and temperature-hardened IC components for the Hi-Reliability marketplace. The company designs and develops high density SRAMs and logic ICs using its patented HardSIL technologies The company was founded by Wesley Harold Morris in 2004 and is headquartered in Austin, TX.

Svelte Medical Systems, Inc. develops balloon expandable stents. It offers balloon control band technologies, hybrid stent design and integrated delivery systems. The firm has locations in Brussels, New Providence and Sao Paulo. The company was founded by Robert E. Fischell, David R. Fischell and Tim A. Fischell in 2007 and is headquartered in New Providence, NJ.

BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands.

Ferric, Inc. develops integrated circuits and integrated inductors in CMOS technology for use in on-chip voltage regulators. Its products include chips and circuit IP, power management IC, packaged integrated voltage regulators and stack integrated voltage regulators. The firm offers power converters utilizing inductors. Its technology can be applies across a broad spectrum of power electronics ranging from full scale servers to the chip level. The company was founded in 2011 by Noah Sturcken, Maurizio Arienzo and Kenneth Shepard and is headquartered in New York, NY.

Livingston International, Inc. engages in provision of customs brokerage, transportation and integrated logistics services. Its services include customs brokerage, U.S. customs brokerage, Canadian customs brokerage, Mexican customs brokerage, freight and transportation, global trade management, trade consulting, trade technology, business process services, trade sphere and vehicle transportation services. The company was founded by Gerry Livingston in 1945 and is headquartered in Toronto, Canada.

Vascular Therapeutics, Inc. develops glycol therapeutics for cardiovascular diseases. The firm also discovers and develops therapeutic agents to prevent & treat life-threatening blood clotting disorders. It serves cardiovascular diseases such as acute myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. The company was founded in July, 1994 and is headquartered in Mountain View, CA.

Brightvolt Solid State Batteries provides embedded power solutions. It also develops custom solid state thin film batteries and power solutions for client’s IoT devices; flexion solid state thin film lithium polymer batteries; and thin micro electronics. The company was founded by Robert Singleton and Craig Nelson in 2001 and is headquartered in Redmond, WA.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Dali Wireless, Inc. provides wireless coverage and capacity solutions. Its products include cellular, public safety, and software. It offers all digital distributed antenna system, dynamic capacity allocation, coverage extension, and radio access network virtualization solutions. The company was founded by Leo K. Wong, Albert S. Lee and Dali Yang in 2006 and is headquartered Menlo Park, CA.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.

Danske Spil A/S provides lotteries and gambling services. The company was founded on July 21, 1948 and is headquartered in Brondby, Denmark.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Tigerconnect, Inc. provides secure mobile messaging services. It offers secure, real-time mobile messaging for the enterprise, empowering organizations to work more securely. The company serves healthcare, enterprise, personal and developers. The company was founded by Jeffrey Albert Evans, Andrew A. Brooks and Brad Brooks in 2010 and is headquartered in Santa Monica, CA.

Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Ventinova Medical BV develops and markets products in the field of anesthesiology. Its products include Ventrain, Cricath, and Ventrain Emergency Kit. The company was founded by Dirk van Asseldonk in 2013 and is headquartered in Eindhoven, Netherlands.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA.

SurgVision BV provides optical imaging camera systems. It develops integrated optical imaging platforms, including camera, software and target specific tracer, for specific disease areas like breast cancer surgery. The company was founded by Vasilis Ntziachristos and Ton van den Hoven in 2011 and is headquartered in 't Harde, the Netherlands.

zeotap GmbH offers a solution for telecom operators. It provides a technology platform that transmits data securely and in a privacy-compliant way for businesses and consumers. The company was founded by Daniel Heer, Stephan Schwebe and Projjol Banerjea and is headquartered in Berlin, Germany.

Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom.

Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom.

Staten Biotechnology BV develops drugs for the treatment of dyslipidemia. The company was founded by Paul da Silva Jardine, Daniel Rader and Alan Tall in 2014 and is headquartered in Nijmegen, the Netherlands.

Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom.

Pakal Technologies, Inc. provides and designs next generation of IGTO power devices. The company is headquartered in San Francisco, CA.

Sirius Medical BV engages in medical industry. The firm focuses on developing medical devices for oncological surgery. The company was founded by Hubert Martens and Bram Schermers and is headquartered in Eindhoven, the Netherlands.

Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.